Enfuvirtide administration in HIV-positive transgender patient with soft tissue augmentation: US evaluation
Gabrielli, E.; Ferraioli, G.; Ferraris, L.; Riva, A.; Galli, M.; Filice, C.; Gervasoni, C.
New Microbiologica 33(3): 263-265
2010
ISSN/ISBN: 1121-7138 PMID: 20954446 Document Number: 638799
Enfuvirtide is a large protein that should be injected subcutaneously to ensure an appropriate absorption. Here we report the case of a transgender HIV-positive patient receiving enfuvirtide with an individualized background regimen of antiretroviral drugs, who had previously undergone liquid silicone oil injections. We performed US scan to detect silicone-free areas for following enfuvirtide injections. US can be useful in the correct management of those patients with liquid silicone oil soft tissue augmentation who require subcutaneously injected drugs.